Inversely, Luo et al. (2020) pointed that expression levels of IL-38 and Th17 cells (including IL-17 and IL-23) were decreased in pSS patients than non-pSS group and healthy control group. This evidence concerns the gene IL1F10 and peeling skin syndrome.